Successful treatment of encapsulating peritoneal sclerosis with azathioprine and prednisolone
Wong, C.F.; Beshir, S.; Khalil, A.; Pai, P.; Ahmad, R.
Peritoneal Dialysis International Journal of the International Society for Peritoneal Dialysis 25(3): 285-287
2005
ISSN/ISBN: 0896-8608 PMID: 15981777 Document Number: 584483
Document emailed within 1 workday
Related Documents
Yamamoto, R.; Nakayama, M.; Hasegawa, T.; Miwako, N.; Yamamoto, H.; Yokoyami, K.; Ikeda, M.; Kato, N.; Hayakawa, H.; Takahashi, H.; Otsuka, Y.; Kawaguchi, Y.; Hosoya, T. 2002: High-transport membrane is a risk factor for encapsulating peritoneal sclerosis developing after long-term continuous ambulatory peritoneal dialysis treatment Advances in Peritoneal Dialysis. Conference on Peritoneal Dialysis 18: 131-134Nakamoto, H. 2005: Encapsulating peritoneal sclerosis--a clinician's approach to diagnosis and medical treatment Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis 25(Suppl 4): S30-S38
Banoth, P.; Khanna, R. 2017: Bleeding Peritoneum During Peritoneal Dialysis: a Case of Early Encapsulating Peritoneal Sclerosis? Advances in Peritoneal Dialysis. Conference on Peritoneal Dialysis 33(2017): 50-54
Matsuoka, T.; Maeda, Y.; Matsuo, K.; Naiki, Y.; Tamai, Y.; Sakaguchi, M.; Hasegawa, H.; Funauchi, M.; Kanamaru, A. 2008: Hepatocyte growth factor prevents peritoneal fibrosis in an animal model of encapsulating peritoneal sclerosis Journal of Nephrology 21(1): 64-73
Honda, K.; Nitta, K.; Horita, S.; Tsukada, M.; Itabashi, M.; Nihei, H.; Akiba, T.; Oda, H. 2003: Histologic criteria for diagnosing encapsulating peritoneal sclerosis in continuous ambulatory peritoneal dialysis patients Advances in Peritoneal Dialysis. Conference on Peritoneal Dialysis 19: 169-175
Yamamoto, H.; Nakayama, M.; yamamoto, R.; Otsuka, Y.; Takahashi, H.; Kato, N.; Hayakawa, H.; Hasegawa, T.; Ikeda, M.; Yokoyama, K.; Kawaguchi, Y.; Mukai, H.; Hosoya, T. 2002: Fifteen cases of encapsulating peritoneal sclerosis related to peritoneal dialysis: a single-center experience in Japan Advances in Peritoneal Dialysis. Conference on Peritoneal Dialysis 18: 135-138
Hendriks, M.P.; de Sévaux, R.G.L.; Hilbrands, L.B. 2008: Encapsulating peritoneal sclerosis in patients on peritoneal dialysis Netherlands Journal of Medicine 66(7): 269-274
Durić, P.; Majster, Z.; Popović, V.Stanković.; Radović, V.Maslarević.; Dimković, N. 2013: Encapsulating peritoneal sclerosis--case report Medicinski Pregled 66(3-4): 185-188
de Vos Tot Nederveen Cappel, W.H.; Dubbeld, J.; Willems, S.M.; Ringers, J.; van Hoek, B. 2008: Liver transplantation in a patient with encapsulating peritoneal sclerosis Netherlands Journal of Medicine 66(7): 280-282
Summers, A.M.; Brenchley, P.E.C. 2006: An international encapsulating peritoneal sclerosis registry and DNA bank: why we need one now Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis 26(5): 559-563
Kawanishi, H.; Ide, K.; Yamashita, M.; Shimomura, M.; Moriishi, M.; Tsuchiya, S.; Dohi, K. 2008: Surgical techniques for prevention of recurrence after total enterolysis in encapsulating peritoneal sclerosis Advances in Peritoneal Dialysis. Conference on Peritoneal Dialysis 24: 51-55
Duman, S.; Bozkurt, D.; Sipahi, S.; Sezak, M.; Ozkan, S.; Ertilav, M.; Sen, S.; Ok, E. 2008: Effects of everolimus as an antiproliferative agent on regression of encapsulating peritoneal sclerosis in a rat model Advances in Peritoneal Dialysis. Conference on Peritoneal Dialysis 24: 104-110
Guest, S. 2009: Tamoxifen therapy for encapsulating peritoneal sclerosis: mechanism of action and update on clinical experiences Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis 29(3): 252-255
Oka, K.; Shimodaira, H.; Hirano, T.; Sakurai, E.; Tamaki, T.; Kozaki, M. 1993: Comparison of adrenal functions in kidney transplant recipients with different long-term immunosuppressive treatments--prednisolone and azathioprine versus prednisolone and cyclosporine Transplantation 56(3): 603-609
Lhermitte, F.; Marteau, R.; de Saxcé, H. 1987: Treatment of progressive and severe forms of multiple sclerosis using a combination of antilymphocyte serum, azathioprine and prednisone. Clinical and biological results. Comparison with a control group treated with azathioprine and prednisone only. 4-year follow-up Revue Neurologique (Paris) 143(2): 98-107
Reissi, D.; Bardideh, A.; Samadzadeh, B.; Razi, A. 1995: Retrospective study of cyclosporine-prednisolone versus cyclosporine-azathioprine-prednisolone immunosuppression in living donor kidney transplantation Transplantation Proceedings 27(5): 2685-2686
Brynger, H.; Persson, H.; Flatmark, A.; Albrechtsen, D.; Frödin, L.; Tufvesson, G.; Gäbel, H.; Weibull, H.; Möller, E.; Lundgren, G. 1988: No effect of blood transfusions or HLA matching on renal graft success rate in recipients treated with cyclosporine-prednisolone or cyclosporine-azathioprine-prednisolone: the Scandinavian experience Transplantation Proceedings 20(3 Suppl 3: 261-263
Frick, E.; Angstwurm, H.; Strauss, G. 1974: Immunosuppressive treatment of multiple sclerosis. 3. Results of treatment with azathioprine and antilymphocytic globulin Münchener Medizinische Wochenschrift 116(48): 2105-2112
Bretagne, J.F.; Raoul, J.L.; Siproudhis, L.; Cado, J.P.; Gosselin, M. 1991: Successful treatment of fulminant Crohn's colitis with azathioprine Gastroenterologie Clinique et Biologique 15(8-9): 654-655
Rubio-Terrés, C.; Domínguez-Gil Hurlé, A. 2005: Cost-utility analysis of relapsing-remitting multiple sclerosis treatment with azathioprine or interferon beta in Spain Revista de Neurologia 40(12): 705-710